Dimitris Voliotis

Dimitris Voliotis

Chief Tech/Sci/R&D Officer at RADIOPHARM THERANOSTICS LIMITED
63 year
Health Technology
Consumer Services
Health Services

Profile

Dr. Dimitris Voliotis, MD, is a Chief Medical Officer at Radiopharm Theranostics Ltd. Dr. Voliotis was previously employed as a Senior Vice President-Clinical Development by Zentalis Pharmaceuticals, Inc., a Chief Development Officer by CureVac AG, a Global Head-Clinical Development Oncology by Eisai, Inc., and a Vice President & Head-Oncology Group by Bayer HealthCare AG.
He received his doctorate degree from Universität zu Köln.

Dimitris Voliotis active positions

CompaniesPositionStart
RADIOPHARM THERANOSTICS LIMITED Chief Tech/Sci/R&D Officer 20/08/2024

Former positions of Dimitris Voliotis

CompaniesPositionEnd
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2023
Corporate Officer/Principal 01/02/2020
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/09/2014
See the detail of Dimitris Voliotis's experience

Education of Dimitris Voliotis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

  1. Stock Market
  2. Insiders
  3. Dimitris Voliotis